Phibro Animal Health Corporation provided consolidated earnings guidance for the year ending June 30, 2024. For the year, the company expects Net sales of $980 million to $1.02 billion, growth of 2%, Net income of $23 million to $28 million, a decline of 22% and Diluted EPS of $0.57 to $0.69, a decline of 22%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.48 USD | +1.45% | -1.69% | +50.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.95% | 708M | |
+21.88% | 8.97B | |
+22.25% | 3.61B | |
-4.17% | 3.08B | |
+11.66% | 1.66B | |
-5.18% | 1.23B | |
-30.83% | 1.15B | |
-31.96% | 1.14B | |
-24.53% | 985M | |
-13.36% | 905M |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024